Methods: Patients were randomized to placebo, mirabegron 50 or 100 mg, or tolterodine extended release (ER) 4 mg orally, once-daily, for 12 weeks. For the post hoc analysis, the primary patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback